| Literature DB >> 35819087 |
Xiuqiao Xie1, Yuanshuai Huang1, Xueyuan Huang2, Rong Gui2.
Abstract
OBJECTIVE: To analyze the use of packed red blood cells (PRBCs) for patients with pelvic fracture and evaluate factors associated with PRBC transfusion for patients with pelvic fracture.Entities:
Keywords: Erythrocyte transfusion; Fracture; Fracture fixation; Hemoglobins analysis; Pelvic bones injuries; Shock; bone classification; hemorrhagic
Mesh:
Substances:
Year: 2022 PMID: 35819087 PMCID: PMC9363721 DOI: 10.1111/os.13330
Source DB: PubMed Journal: Orthop Surg ISSN: 1757-7853 Impact factor: 2.279
Fig. 1A 63‐year old male patient with HE‐PFs. (A) CT showed bilateral acetabulum, bilateral superior and inferior ramus of pubis, right sacrum, and iliac crest fractures. (B) Another pelvic radiography of the same patient was taken 1 week after open reduction and internal fixation
Fig. 2A 50‐year old male patients with HE‐PFs. (A) Pelvic radiograph showed superior and inferior ramus of pubis fracture. (B) Another pelvic radiography of the same patient was taken 1 week after closed reduction and external fixation
Fig. 3A 57‐year old male patients with LE‐PFs. Pelvic radiograph showed fractures on the left superior and inferior pubic ramus and right inferior pubic ramus
Fig. 4Selection and grouping methods for all 551 patients
Baseline and characteristics of pelvic fracture patients
| HE‐PF group ( | LE‐PF group ( | Total ( |
|
| |
|---|---|---|---|---|---|
| Age (years) | 73.158 | <0.001 | |||
| <65 | 178 (77.4%) | 23 (25.8%) | 201 (63%) | ||
| ≥65 | 52 (22.6%) | 66 (74.2%) | 118 (37%) | ||
| Gender | 19.709 | <0.001 | |||
| Male | 146 (63.5%) | 32 (36%) | 178 (55.8%) | ||
| Female | 84 (36.5%) | 57 (64%) | 141 (44.2%) | ||
| Co‐existing diseases | |||||
| Angiocardiopathy | 21 (9.1%) | 51 (57.3%) | 72 (22.6%) | 85.209 | <0.001 |
| Diabetes | 13 (5.7%) | 17 (19.1%) | 30 (9.4%) | 13.623 | <0.001 |
| Osteoporosis | 2 (0.9%) | 50 (56.2%) | 52 (16.3%) | 143.881 | <0.001 |
| Others | 20 (8.7%) | 18 (20.2%) | 38 (11.9%) | 8.128 | 0.004 |
| Accompanying fracture sites | |||||
| Skull bones | 5 (2.2%) | 0 (0%) | 5 (1.6%) | / | 0.327 |
| Trunk bones | 37 (16.1%) | 7 (7.9%) | 44 (13.8%) | 3.648 | 0.056 |
| Extremity bones | 54 (23.5%) | 8 (9%) | 62 (19.4%) | 8.604 | 0.003 |
| Acetabulum | 82 (35.7%) | 13 (14.6%) | 95 (29.8%) | 13.591 | <0.001 |
| Associated injuries | |||||
| Head injuries | 28 (12.2%) | 2 (2.2%) | 30 (9.4%) | 7.422 | 0.006 |
| Nerve injuries | 12 (5.2%) | 0 (0%) | 12 (3.8%) | / | 0.023 |
| Abdominal injuries | 98 (42.6%) | 2 (2.2%) | 100 (31.3%) | 48.573 | <0.001 |
| Genitourinary injuries | 46 (20%) | 1 (1.1%) | 47 (14.7%) | 18.2 | <0.001 |
| Retroperitoneal hematoma | 8 (3.5%) | 0 (0%) | 8 (2.5%) | / | 0.112 |
| Hemorrhagic shock | 47 (20.4%) | 3 (3.4%) | 50 (15.7%) | 14.137 | <0.001 |
| Others | 94 (40.9%) | 11 (12.4%) | 105 (32.9%) | 23.621 | <0.001 |
| Pelvis AIS | 3 (2–3) | 3 (2–3) | 3 (2–3) | −0.046 | 0.963 |
Abbreviations: AIS, abbreviated injury scale; HE‐PF, high‐energy pelvic fracture; LE‐PF, low‐energy pelvic fracture.
Clinical outcomes of pelvic fracture patients
| HE‐PF group ( | LE‐PF group ( | Total ( |
|
| |
|---|---|---|---|---|---|
| HTR | 3 (1.3%) | 0 (0%) | 3 (0.9%) | / | 0.563 |
| ATR | 2 (0.9%) | 0 (0%) | 2 (0.6%) | / | 1 |
| TRALI | 2 (0.9%) | 3 (3.4%) | 5 (1.6%) | / | 0.135 |
| Pressure ulcers | 3 (1.3%) | 2 (2.2%) | 5 (1.6%) | / | 0.621 |
| DVT | 6 (2.6%) | 0 (0%) | 6 (1.9%) | / | 0.191 |
| Pelvic reduction quality on discharge | |||||
| Excellent | 43 (18.7%) | 9 (17.3%) | 52 (16.3%) | 3.465 | 0.063 |
| Good | 105 (45.7%) | 66 (74.2%) | 171 (53.6%) | 20.965 | <0.001 |
| Fair | 54 (23.5%) | 11 (12.4%) | 65 (20.4%) | 5.89 | 0.027 |
| Poor | 28 (12.2%) | 3 (3.4%) | 31 (9.7%) | 5.668 | 0.017 |
| Dead | 3 (1.3%) | 1 (1.1%) | 4 (1.3%) | / | 1 |
| Hospital stay | 22 (17–29) | 18 (13–22) | 21 (16–27) | −4.395 | <0.001 |
Abbreviations: ATR, allergic transfusion reaction; DVT, deep venous thrombosis; HE‐PF, high‐energy pelvic fracture; HTR, Hemolytic transfusion reaction; LE‐PF, low‐energy pelvic fracture; TRALI, transfusion‐related acute lung injury.
Tile classification of pelvic fracture patients
| HE‐PF group ( | LE‐PF group ( | Total ( |
|
| |
|---|---|---|---|---|---|
| A1 | 15 (6.5%) | 16 (18%) | 31 (9.7%) | 9.599 | 0.002 |
| A2 | 63 (27.4%) | 49 (55.1%) | 112 (35.1%) | 21.556 | < 0.001 |
| A3 | 9 (3.9%) | 0 (0%) | 9 (2.8%) | / | 0.067 |
| B1 | 53 (23%) | 11 (12.4%) | 64 (20.1%) | 4.567 | 0.033 |
| B2 | 16 (7%) | 5 (5.6%) | 21 (6.6%) | 0.187 | 0.665 |
| B3 | 26 (11.3%) | 4 (4.5%) | 30 (9.4%) | 3.493 | 0.062 |
| C1 | 16 (7%) | 1 (1.1%) | 17 (5.3%) | / | 0.048 |
| C2 | 15 (6.5%) | 1 (1.1%) | 16 (5%) | / | 0.049 |
| C3 | 17 (7.4%) | 2 (2.2%) | 19 (6%) | 3.031 | 0.082 |
Abbreviations: HE‐PF, high‐energy pelvic fracture; LE‐PF, low‐energy pelvic fracture.
Results of blood tests on admission associated with transfusion
| HE‐PF group ( | LE‐PF group ( | Total ( |
|
| |
|---|---|---|---|---|---|
| Blood routine tests | |||||
| Hb (g/L) | 4.635 | 0.031 | |||
| <70 | 40 (21.3%) | 7 (16.9%) | 47 (20.1%) | ||
| ≥70 | 190 (78.7%) | 82 (83.1%) | 272 (79.9%) | ||
| Hct (%) | 9.464 | 0.002 | |||
| <30 | 142 (61.7%) | 38(42.7%) | 180(56.4%) | ||
| ≥30 | 88 (38.3%) | 51 (57.3%) | 139 (43.6%) | ||
| PC (X109/L) | 0.792 | 0.373 | |||
| <100 | 49 (21.3%) | 15 (16.9%) | 64 (20.1%) | ||
| ≥100 | 181 (78.7%) | 74 (83.1%) | 255 (79.9%) | ||
| PT (s) | / | 0.57 | |||
| <21 | 217 (94.3%) | 86 (96.6%) | 303 (95%) | ||
| ≥21 | 13 (5.7%) | 3 (3.4%) | 16 (5%) | ||
| APTT (s) | 1.473 | 0.225 | |||
| <56 | 214 (93%) | 86 (96.6%) | 300 (94%) | ||
| ≥56 | 16 (7%) | 3 (3.4%) | 19 (6%) | ||
Abbreviations: APTT, activated partial thromboplastin time; Hb, hemoglobin; Hematocrit, Hct; HE‐PF, high‐energy pelvic fracture; LE‐PF, low‐energy pelvic fracture; PC, platelet count; PT, prothrombin time.
Types of the in‐hospital procedures performed for pelvic fracture patients
| HE‐PF group ( | LE‐PF group ( | Total ( |
|
| |
|---|---|---|---|---|---|
| ASA | 2 (1–3) | 2 (2–2) | 2 (1–3) | −0.245 | 0.807 |
| Emergency surgeries | |||||
| Exploratory laparotomy | 14 (6.1%) | 0 (0%) | 14 (4.4%) | / | 0.013 |
| Pelvic packing | 2 (0.9%) | 0 (0%) | 2 (0.6%) | / | 1 |
| Angiographic embolization | 5 (2.2%) | 0 (0%) | 5 (1.6%) | / | 0.327 |
| Ruptured organ resection | 7 (3%) | 0 (0%) | 7 (2.2%) | / | 0.197 |
| Stabilization methods | |||||
| IF | 168 (73%) | 36 (40.4%) | 204 (63.9%) | 29.57 | < 0.001 |
| EF | 35 (15.2%) | 47 (52.8%) | 82 (25.7%) | 47.482 | < 0.001 |
| Conservative treatment | 27 (11.7%) | 6 (6.7%) | 33 (10.3%) | 1.728 | 0.189 |
| Other elective surgeries | |||||
| Craniotomy | 8 (3.5%) | 1 (1.1%) | 9 (2.8%) | / | 0.453 |
| Extremity fracture fixation | 103 (44.8%) | 41 (46.1%) | 144 (45.1%) | 0.043 | 0.836 |
| Trunk bone fixation | 20 (8.7%) | 4 (4.5%) | 24 (7.5%) | 1.628 | 0.202 |
| Vascular surgeries | 14 (6.1%) | 4 (4.5%) | 18 (5.6%) | 0.306 | 0.58 |
| Others | 13 (5.7%) | 1 (1.1%) | 14 (4.4%) | / | 0.123 |
Abbreviations: ASA, The American Society of Anesthesiologists; EF, external fixation; HE‐PF, high‐energy pelvic fracture; IF, internal fixation; LE‐PF, low‐energy pelvic fracture.
Medications and blood products used for pelvic fracture patients
| HE‐PF group ( | LE‐PF group ( | Total |
|
| |
|---|---|---|---|---|---|
| ( | |||||
| Hemostatic drugs | 33 (14.3%) | 28 (3.1%) | 61 (19.1%) | 12.151 | <0.001 |
| Iron supplement agents | 83 (36.1%) | 5 (0.6%) | 88 (27.6%) | 29.822 | <0.001 |
| Autologous blood transfusions | 14 (6.1%) | 2 (0.2%) | 16 (5%) | / | 0.252 |
| PRBCs (unit) | 4.5 (3–8) | 3.5 (2–4.5) | 4 (3–7) | −3.766 | <0.001 |
| FFP (ml) | 300 (0–600) | 0 (0–295) | 200 (0–600) | −3.821 | <0.001 |
| Platelets (unit | 0 (0–0) | 0 (0–0) | 0 (0–0) | −1.249 | 0.212 |
| Cryoprecipitate (unit) | 0 (0–0) | 0 (0–0) | 0 (0–0) | −1.417 | 0.157 |
| Albumin (g) | 0 (0–30) | 0 (0–0) | 0 (0–10) | −5.944 | <0.001 |
Abbreviations: FFP, fresh frozen plasma; HE‐PF, high‐energy pelvic fracture; LE‐PF, low‐energy pelvic fracture; PRBCs, packed red blood cells.
Factors that were statistically associated with PRBCs
| No. of patients | PRBCs (unit) |
|
| |
|---|---|---|---|---|
| Age | −3.103 | 0.002 | ||
| <65 | 201 (60.5%) | 4.5 (3–8) | ||
| ≥65 | 118 (35.5%) | 3.5 (2–5.5) | ||
| Gender | −3.248 | 0.001 | ||
| Male | 178 (53.6%) | 4.5 (3–8) | ||
| Female | 141 (42.4%) | 3.5 (2–6) | ||
| Angiocardiopathy | −2.24 | 0.025 | ||
| Yes | 72 (22.6%) | 3.5 (2.5–5.9) | ||
| No | 247 (77.4%) | 4 (3–8) | ||
| Diabetes | −2.086 | 0.037 | ||
| Yes | 30 (9.4%) | 3.3 (2.4–4) | ||
| No | 289 (90.6%) | 4 (3–7.5) | ||
| Osteoporosis | −4.508 | < 0.001 | ||
| Yes | 52 (16.3%) | 3 (2–4) | ||
| No | 267 (83.7%) | 4 (3–8) | ||
| Abdominal injuries | −2.984 | 0.003 | ||
| Yes | 100 (31.3%) | 5.3 (3–8.5) | ||
| No | 219 (68.7%) | 4 (3–6) | ||
| Genitourinary injuries | −3.157 | 0.002 | ||
| Yes | 47 (14.7%) | 5.5 (4–8.5) | ||
| No | 272 (85.3%) | 4 (2.6–6.5) | ||
| Hemorrhagic shock | −4.986 | < 0.001 | ||
| Yes | 50 (15%) | 7.8 (4–17) | ||
| No | 269 (85%) | 4 (2.4–6) | ||
| Tile classification | 25.314 | 0.001 | ||
| A1 | 31 (9.3%) | 4 (2.5–5.5) | ||
| A2 | 112 (33.7%) | 3.8 (2–5.5) | ||
| A3 | 9 (2.7%) | 7 (1.8–8.5) | ||
| B1 | 64 (19.2%) | 4 (3–5.5) | ||
| B2 | 21 (6.3%) | 4 (3–8) | ||
| B3 | 30 (9%) | 4.3 (2.8–8.3) | ||
| C1 | 17 (5.1%) | 5.5 (3–11) | ||
| C2 | 16 (4.8%) | 6 (3.3–9) | ||
| C3 | 19 (5.7%) | 8.5 (6–10.5) | ||
| Hb (g/L) | −5.509 | < 0.001 | ||
| <70 | 47 (14.1%) | 8 (4.5–13) | ||
| ≥70 | 272 (81.9%) | 4 (2–6) | ||
| Hct (%) | −2.895 | 0.004 | ||
| <30 | 180 (54.2%) | 4.5 (3–8) | ||
| ≥30 | 139 (41.8%) | 3.5 (2–6) | ||
| PC (X109/L) | −2.869 | 0.004 | ||
| <100 | 64 (19.2%) | 5.8 (3–11.8) | ||
| ≥100 | 255 (76.8%) | 4 (3–6) | ||
| PT (s) | −2.4 | 0.016 | ||
| <21 | 303 (91.2%) | 4 (3–6.5) | ||
| ≥21 | 16 (4.8%) | 8 (4.1–14) | ||
| APTT (s) | −3.352 | 0.001 | ||
| <56 | 300 (90.3%) | 4 (3–6.5) | ||
| ≥56 | 19 (5.7%) | 9 (4–15) | ||
| Exploratory laparotomy | −3.449 | 0.001 | ||
| Yes | 14 (4.4%) | 7.8 (4.9–15.1) | ||
| No | 305 (95.6%) | 4 (3–6.6) | ||
| Angiographic embolization | −2.302 | 0.021 | ||
| Yes | 5 (1.6%) | 8 (5.5–23.5) | ||
| No | 314 (98.4%) | 4 (3–7) | ||
| Ruptured organ resection | −3.329 | 0.001 | ||
| Yes | 7 (2.2%) | 13 (6.5–16.5) | ||
| No | 312 (97.8%) | 4 (3–6.8) | ||
| Stabilization methods | 6.187 | 0.045 | ||
| IF | 204 (63.9%) | 4 (3–7.9) | ||
| EF | 82 (25.7%) | 3.5 (2–5.6) | ||
| Conservative treatment | 33 (10.3%) | 4 (2–6.5) | ||
| Extremity fracture fixation | −2.813 | 0.005 | ||
| Yes | 144 (45.1%) | 4.5 (3–8) | ||
| No | 175 (54.9%) | 4 (2–6) | ||
| Hemostatic drugs | −3.585 | < 0.001 | ||
| Yes | 88 (26.5%) | 4.5 (4–8.5) | ||
| No | 231 (69.5%) | 4 (2–6) | ||
Abbreviations: APTT, activated partial thromboplastin time; EF, external fixation; Hb, hemoglobin; Hematocrit, Hct; IF, internal fixation; PC, platelet count; PRBCs, packed red blood cells; PT, prothrombin time.
Optimal scale regression for perioperative transfusion of PRBCs
| Independent variable with significance | Assignment |
|
|
| Importance |
|---|---|---|---|---|---|
| Hemorrhagic shock on admission | 1 = no 2 = yes | 0.235 | 8.495 | 0.004 | 0.283 |
| Tile classification |
1 = A1 2 = A2 3 = A3 4 = B1 5 = B2 6 = B3 7 = C1 8 = C2 9 = C3 | −0.158 | 10.017 | 0 | 0.156 |
| Hb levels |
1 = below 70g/L 2 = at and above 70g/L | −0.14 | 4.313 | 0.039 | 0.148 |
| Stabilization methods |
1 = IF 2 = EF 3 = Conservative treatment | −0.096 | 3.699 | 0.026 | 0.008 |
Abbreviations: EF, external fixation; Hb, hemoglobin; IF, internal fixation.